(Q42164571)

English

Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis

scientific article published on February 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Glatiramer acetate reduces lymphocyte proliferation and enhances IL-5 and IL-13 production through modulation of monocyte-derived dendritic cells in multiple sclerosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

multiple sclerosis

0 references

1 reference

based on heuristic

inferred from title

author name string

Sanna A

1

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Fois ML

2

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Arru G

3

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Huang YM

4

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Link H

5

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Pugliatti M

6

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Rosati G

7

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Sotgiu S

8

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

publication date

1 February 2006

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Clinical and Experimental Immunology

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

143

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

357-362

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Dendritic cells and the control of immunity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.02997.X

21 January 2018

T-cell priming by type-1 and type-2 polarized dendritic cells: the concept of a third signal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.02997.X

21 January 2018

Glatiramer Acetate (Copolymer-1, Copaxone) Promotes Th2 Cell Development and Increased IL-10 Production Through Modulation of Dendritic Cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.02997.X

21 January 2018

Glatiramer acetate (Copaxone): comparison of continuous versus delayed therapy in a six-year organized multiple sclerosis trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.02997.X

21 January 2018

Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factorin situ

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.02997.X

21 January 2018

Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.02997.X

21 January 2018

Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.02997.X

21 January 2018

Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-10 production in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.02997.X

21 January 2018

Induction of apoptosis of CD4+ T cells by immunomodulatory therapy of multiple sclerosis with glatiramer acetate

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.02997.X

21 January 2018

Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.02997.X

21 January 2018

Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.02997.X

21 January 2018

Glatiramer acetate in multiple sclerosis: update on potential mechanisms of action

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.02997.X

21 January 2018

Glatiramer acetate (GA) induces IL-13/IL-5 secretion in naive T cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.02997.X

21 January 2018

Coordinate regulation of the IL-4, IL-13, and IL-5 cytokine cluster in Th2 clones revealed by allelic expression patterns

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2249.2006.02997.X

21 January 2018

Inflammation in the central nervous system: the role for dendritic cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809576

11 October 2018

Glatiramer acetate.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809576

11 October 2018

Human dendritic cells require exogenous interleukin-12-inducing factors to direct the development of naive T-helper cells toward the Th1 phenotype.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1809576

11 October 2018

Cerebrospinal fluid affects phenotype and functions of myeloid dendritic cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/16412061

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferons in relapsing remitting multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16412061

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Humanized antibodies against an adhesion molecule block the CNS inflammation in multiple sclerosis]

1 reference

https://pubmed.ncbi.nlm.nih.gov/16412061

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dendritic cells, obtained from peripheral blood precursors in the presence of PGE2, promote Th2 responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/16412061

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of Th1-inducing capacity in myeloid dendritic cells requires environmental instruction

1 reference

https://pubmed.ncbi.nlm.nih.gov/16412061

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/J.1365-2249.2006.02997.X

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

PMC publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42164571&oldid=1935059859"